Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CurifyLabs logo — Automated compounding of personalized medicine

CurifyLabs

Automated compounding of personalized medicine

Founded 2021 Finland Finland 33 employees Series A Total: $24.31M Biotechnology, Health Care +2

General Information

Company Name CurifyLabs
Founded Year 2021
Location Finland Finland
Employees 33
Industries Biotechnology, Health Care, Pharmaceutical +1
Funding Stage Series A
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with CurifyLabs. To contact CurifyLabs, visit curifylabs.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CurifyLabs compare?

A PDF of CurifyLabs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CurifyLabs soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CurifyLabs

CurifyLabs, established in 2021 in Finland, is a pioneering healthtech startup specializing in the automated compounding of personalized medicine. Operating in the intersections of Biotechnology, Health Care, Pharmaceutical, and 3D Printing industries, the company is transforming how personalized medicines are produced in pharmacies and hospitals.

The company’s flagship innovation, the Compounding System Solution (CSS), offers a sophisticated yet user-friendly platform that automates the traditionally manual and time-intensive process of pharmaceutical compounding. The CSS supports non-sterile dosage forms, ensuring precise, in-process quality control, thus enabling better patient care and operational efficiencies for healthcare providers across Europe and the US.

In May 2025, CurifyLabs secured a €6.70M Debt Financing investment from Springvest Oyj, underscoring investor confidence in its innovative solutions and growth potential in personalized medicine manufacturing.

Business keywords: Healthtech, Personalized Medicine, Pharmaceutical Compounding, Automated Manufacturing, 3D Printing in Pharmaceuticals, Non-Sterile Dosage Forms, Pharmacy Automation, Hospital Pharmacy Solutions, Compounding Robotics, In-Process Quality Control, GMP Standards, Formulation Library, Cost Efficiency, Patient Safety, Mass Customization of Medicines

Services & Products

Automated Compounding Systems
Compounding Software Platform
Robotics for Pharmacy
Personalized Dosage Forms
Excipient Bases Production

Target Customers

Pharmacists Hospital Pharmacies Compounding Retail Pharmacies Pediatric Cancer Treatment Centers Healthcare Providers for Underserved Populations

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €12.00M 4
Lifeline Ventures HealthCap Sandwater
Lifeline Ventures, HealthCap +2
06 Jul 2026
Debt Financing €6.70M 1
Springvest Oyj
Springvest Oyj
01 May 2025
Grant €2.48M 1
European Innovation Council
European Innovation Council
01 Jan 2023
Seed €2.00M 1
Lifeline Ventures
Lifeline Ventures
01 Apr 2022
Seed €830.00K 2
Avohoidon Tutkimussäätiö Apteekkien Eläkekassa
Avohoidon Tutkimussäätiö, Apteekkien Eläkekassa
01 Nov 2021
Seed $300.00K -
01 Apr 2021

Latest News

View All
Finland’s CurifyLabs raises $14M to 3D-print personalised medicine in the US — Thenextweb
Finland’s CurifyLabs raises $14M to 3D-print personalised medicine in the US
Thenextweb Jul 06, 2026
Finland’s CurifyLabs raises €12 million to expand 3D printing-based medicine compounding — Eu-startups
Finland’s CurifyLabs raises €12 million to expand 3D printing-based medicine compounding
Eu-startups Jul 06, 2026
CurifyLabs bags €12M to automate personalised medicine — Tech
CurifyLabs bags €12M to automate personalised medicine
Tech Jul 06, 2026
As millions await approved therapies, myTomorrows strengthens its global patient-access mission with... — Eu-startups
As millions await approved therapies, myTomorrows strengthens its global patient-access mission with €25 million
Eu-startups Nov 11, 2025
Finnish HealthTech startup CurifyLabs raises €6.7 million to make medicine safer and more personalis... — Eu-startups
Finnish HealthTech startup CurifyLabs raises €6.7 million to make medicine safer and more personalised
Eu-startups May 27, 2025
CurifyLabs secures €6.7M to launch RoboPharma and redefine drug supply resilience — Tech
CurifyLabs secures €6.7M to launch RoboPharma and redefine drug supply resilience
Tech May 27, 2025

CurifyLabs Alternatives & Competitors

View All Alternatives
CurifyLabs vs
Belmar Pharma Solutions
Belmar Pharma Solutions United States

Belmar Pharmacy, Belmar Select Outsourcing, Belmar Research

Private Equity
142 employees
Biotechnology, Education
Compare CurifyLabs vs Belmar Pharma Solutions
CurifyLabs vs
Empower Pharmacy
Empower Pharmacy United States

Expanding Access

1066 employees
Health Care, Pharmaceutical
Compare CurifyLabs vs Empower Pharmacy
CurifyLabs vs
MYCB1 Group B.V.
MYCB1 Group B.V. The Netherlands

MYCB1 Group B.V. produces, and distributes GMP-grade cannabinoid medicines via its German subsidiar...

Debt Financing
18 employees
AI, Health Care
Also compare with: CurifyLabs vs Doser Doser View all alternatives

FAQ About CurifyLabs

Automated compounding of personalized medicine
CurifyLabs was founded in 2021.
CurifyLabs is headquartered in Finland.
CurifyLabs operates in Biotechnology, Health Care, Pharmaceutical and 3D Printing. Its work centres on Healthtech, Personalized Medicine, Pharmaceutical Compounding and Automated Manufacturing. Its customers include Pharmacists, Hospital Pharmacies and Compounding Retail Pharmacies.
CurifyLabs has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Product Sales and Service Fee.
CurifyLabs has approximately 33 employees.
CurifyLabs has completed 6 funding rounds, raising a total of $24.31M. The latest funding stage is Series A.
CurifyLabs offers: Automated Compounding Systems, Compounding Software Platform, Robotics for Pharmacy, Personalized Dosage Forms, Excipient Bases Production.
Top alternatives and competitors to CurifyLabs include Belmar Pharma Solutions, Empower Pharmacy, MYCB1 Group B.V., Doser, Addis Pharmaceutical Factory. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CurifyLabs and Belmar Pharma Solutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CurifyLabs, https://bouncewatch.com/company/curifylabs, updated 6 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes